Publicado oct 28, 2020



PLUMX
Almetrics
 
Dimensions
 

Google Scholar
 
Search GoogleScholar


María Caicedo-Martínez, MD http://orcid.org/0000-0001-5799-2096

Camila Ordóñez-Reyes, MD http://orcid.org/0000-0002-8941-9064

Ginna Fernández-Deaza, MD http://orcid.org/0000-0002-0080-4071

Raúl Murillo, MD, MPH http://orcid.org/0000-0001-7187-9946

Maeve B Mello, BSc, PhD http://orcid.org/0000-0002-2573-7776

Bernardo Nuche-Berenguer, MPH, PHD http://orcid.org/0000-0001-8694-574X

##plugins.themes.bootstrap3.article.details##

Resumen

Contexto:  Las mujeres que viven con VIH (WLHIV) tienen mayor riesgo de infección por Virus del Papiloma Humano (VPH), y de desarrollar lesiones precancerosas y cáncer cervicouterino. Los sistemas de salud deben integrar servicios de VIH y VPH que contemplen las particularidades de las WLHIV. Objetivos: Sintetizar la evidencia disponible sobre epidemiología del cáncer cervicouterino, y el acceso a servicios de prevención y detección temprana en WLHIV en las Américas. Métodos: Nueve preguntas PICO orientarán una revisión sistemática de literatura publicada en Medline y LILACS, complementada con referencias cruzadas y literatura gris en Trip y Google-Scholar. El protocolo seguirá los estándares de PRISMA-P. Dos investigadores revisarán títulos y resúmenes de manera independiente, los desacuerdos serán resueltos por consenso. La elegibilidad se determinará mediante revisión de texto completo. El riesgo de sesgo será evaluado con instrumentos validados. Tablas de extracción de datos serán desarrolladas para cada pregunta PICO y reportadas en formato estructurado. Dependiendo de los resultados se hará meta-análisis. Discusión: Esta revisión anticipa encontrar información valiosa para decisores y actores de salud pública ya que proveerá información nueva sobre esta población especial en las Américas.

Keywords

: VIH, Neoplasias del Cuello Uterino, Epidemiología, Prevención de Enfermedades, Tamizaje Masivo.Americas, HIV, Uterine Cervical Neoplasms, Cervical Intraepithelial Neoplasia, Mass Screening.

References
1. International Agency for Research on Cancer. Global Cancer Observatory: Cancer Today. [Internet]. Available from: https://gco.iarc.fr/
2. World Health Organization. Draft: Global Strategy Towards the Elimination of Cervical Cancer as a Public Health Program. [Internet]. 2019. Available from: https://www.who.int/docs/default-source/documents/cervical-cancer-elimination-draft-strategy.pdf?sfvrsn=380979d6_4
3. UNAIDS. UNAIDS DATA 2019. In 2019. Available from: https://www.unaids.org/sites/default/files/media_asset/2019-UNAIDS-data_en.pdf
4. Abraham AG, D’Souza G, Jing Y, Gange SJ, Sterling TR, Silverberg MJ, et al. Invasive Cervical Cancer Risk Among HIV-Infected Women: A North American Multicohort Collaboration Prospective Study. JAIDS J Acquir Immune Defic Syndr. 2013 Apr;62(4):405–13.
5. Mohammed D, Shukla P, Babayants Y, Sison R, Slim J. Increased proportions of HIV-infected women met cervical cancer screening guideline in 2016. Int J Womens Health. 2018 Feb;Volume 10:83–7.
6. Liu G, Sharma M, Tan N, Barnabas RV. HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer: AIDS. 2018 Mar;32(6):795–808.
7. Denslow SA, Rositch AF, Firnhaber C, Ting J, JS Smith. Incidence and progression of cervical lesions in women with HIV: A systematic global review. Int J STD AIDS. 2014 Mar;25(3):163–77.
8. Weldegebreal F, Worku T. Precancerous Cervical Lesion Among HIV-Positive Women in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. SAGE. 2019;26:1–11.
9. Clifford GM, Goncalves MAG, Franceschi S. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS. 2006;20:2337–44.
10. Cervical cancer risk in women living with HIV across four continents: A multicohort study - Rohner - 2020 - International Journal of Cancer - Wiley Online Library [Internet]. [cited 2020 Jan 20]. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.32260
11. Clifford GM, Tully S, Franceschi S. Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer. Clin Infect Dis. 2017 May 1;64(9):1228–35.
12. PAHO. Pan American Health Orgnization: Member States [Internet]. [cited 2020 Jan 22]. Available from: https://www.paho.org/hq/index.php?option=com_content&view=article&id=103:member-states&Itemid=1110&lang=fr
13. Pan American Health Organization. Plan of Action for the prevention and control of HIV and sexually transmitted infections 2016-2021. WHO; 2016.
14. Pan American Health Organization. PLAN OF ACTION FOR CERVICAL CANCER PREVENTION AND CONTROL 2018-2030. [Internet]. PAHO; 2018. Available from: https://www.paho.org/hq/index.php?option=com_docman&view=download&category_slug=mandates-strategies-3448&alias=47584-plan-cervical-cancer-2018-2030&Itemid=270&lang=en
15. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009 Dec 4;339(jul21 1):b2700–b2700.
16. Universal health coverage and universal access. - PubMed - NCBI [Internet]. [cited 2020 Jan 20]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/23940398
17. BMJ OPEN. Appraisal tool for Cross-Sectional Studies (AXIS).
18. Guyatt G, Rennie D, Meade M, Cook D, American Medical Association, editors. Users’ guides to the medical literature. A manual for evidence-based clinical practice. Third edition. New York: McGraw-Hill Education Medical; 2015. (JAMAevidence).
19. Lockwood C, et al. Qualitative research synthesis: methodological guidance for systematic reviewers utilizing meta-aggregation. International Journal of Evidence-Based Healthcare. 2015;13:179–87.
20. Ofman J, Sullivan S, Neumann P, Chiun-Fang C, Henning J, Wade S, et al. Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES. J Managed Care Pharm. 2003;9(1):53–61.
21. Kelly H, Weiss HA, Benavente Y, de Sanjose Silvia, Mayaud Philippe. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis. Lancet HIV. 2017 Oct;5:45–58.
22. Menon S, et al. Associations between highly active antiretroviral therapy and the presence of HPV, premalignant and malignant cervical lesions in sub-Saharan Africa, a systematic review: current evidence and directions for future research. BMJ Open. 2017;7:e015123.
Cómo citar
Caicedo-Martínez, M., Ordóñez-Reyes, C., Fernández-Deaza, G., Murillo, R., Mello, M. B., & Nuche-Berenguer, B. (2020). Cervical Cancer Epidemiology, Prevention and Screening among Women Living with HIV in the Americas region: A Systematic Review Protocol: A Systematic Review Protocol. Universitas Medica, 61(4). https://doi.org/10.11144/Javeriana.umed61-4.ccep
Sección
Artículos originales

Artículos más leídos del mismo autor/a